XML 27 R20.htm IDEA: XBRL DOCUMENT v3.25.2
Stockholders' Equity (Tables)
6 Months Ended
Jun. 30, 2025
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Summary of Stock Option Activity

A summary of the Company’s stock option activity under the Plans is as follows (in thousands, except share, per share data and years):

 

 

 

Number of
Options

 

 

Weighted-
Average
Exercise Price

 

 

Weighted-
Average
Remaining
Contractual
Term (in years)

 

 

Aggregate
Intrinsic Value

 

Outstanding at December 31, 2024

 

 

8,873,071

 

 

$

12.81

 

 

 

7.2

 

 

$

361,595

 

Granted

 

 

1,633,261

 

 

$

47.69

 

 

 

 

 

 

 

Exercised

 

 

(140,533

)

 

$

7.66

 

 

 

 

 

 

 

Forfeited or cancelled

 

 

(155,795

)

 

$

41.60

 

 

 

 

 

 

 

Outstanding at June 30, 2025

 

 

10,210,004

 

 

$

18.02

 

 

 

7.1

 

 

$

98,677

 

Vested and expected to vest at June 30, 2025

 

 

10,210,004

 

 

$

18.02

 

 

 

7.1

 

 

$

98,677

 

Exercisable at June 30, 2025

 

 

6,535,340

 

 

$

11.96

 

 

 

6.2

 

 

$

77,974

 

Summary of Fair Value of Stock Option Grants

The assumptions used in the Black-Scholes option pricing model to determine the fair value of stock option grants under the Plans were as follows:

 

 

 

Six Months Ended June 30,

 

 

2025

 

2024

Risk-free interest rate

 

3.9% – 4.4%

 

3.8% – 4.6%

Expected volatility

 

101% – 104%

 

83% – 91%

Expected term (in years)

 

5.3 – 10.0

 

5.3 – 6.1

Expected dividend yield

 

 

Summary of Stock-Based Compensation Expense

Stock-based compensation expense has been reported in the condensed statements of operations and comprehensive loss as follows (in thousands):

 

 

 

Three Months Ended
June 30,

 

 

Six Months Ended
June 30,

 

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Research and development

 

$

5,489

 

 

$

2,324

 

 

$

10,688

 

 

$

4,508

 

General and administrative

 

 

5,471

 

 

 

3,433

 

 

 

10,974

 

 

 

6,874

 

Total

 

$

10,960

 

 

$

5,757

 

 

$

21,662

 

 

$

11,382

 

 

Summary of Common Stock Reserved for Future Issuance

Common stock reserved for future issuance consists of the following:

 

 

 

June 30,
2025

 

 

December 31,
2024

 

Common stock options outstanding

 

 

10,210,004

 

 

 

8,873,071

 

RSUs outstanding

 

 

701,652

 

 

 

341,847

 

Shares available for issuance under the Plans

 

 

6,245,119

 

 

 

5,131,660

 

Shares available for issuance under the ESPP

 

 

2,006,787

 

 

 

1,506,316

 

Pre-funded common stock warrants outstanding

 

 

2,676,804

 

 

 

2,676,804

 

Total

 

 

21,840,366

 

 

 

18,529,698

 

Two Thousand Twenty One Equity Incentive Plan [Member]  
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]  
Summary of RSU Activity

A summary of the Company’s RSU activity under the 2021 Plan is as follows:

 

 

 

Number of
RSUs

 

 

Weighted-
Average Grant Date Fair Value per Share

 

Outstanding at December 31, 2024

 

 

341,847

 

 

$

59.09

 

Granted

 

 

412,730

 

 

$

44.66

 

Vested and settled

 

 

(2,500

)

 

$

39.80

 

Forfeited or cancelled

 

 

(50,425

)

 

$

49.67

 

Outstanding at June 30, 2025(1)

 

 

701,652

 

 

$

51.35

 

 

(1)
This amount includes 14,962 RSUs granted to the Company’s non-employee directors who have elected deferred settlement of the RSUs to a specified date following the first to occur of (i) the date that is 30 days following the date of the director's separation from service for any reason, or (ii) a change in control event.